The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups

Cabezas-Cerrato, J

doi:10.1007/s001250051063

Cited by 171 publications

(113 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the literature, multiple logistic regression analyses showed that age had a significant association with retinopathy and DN. Especially the studies conducted by Wandell, Cheng et al, and Cabezas-Cerrato showed that there were significant correlations between age and DN [9][10][11]. In our study a positive correlation was present between neuropathy and age of the patients as well (r: 0.18, p<0.001).…”

Section: Discussionsupporting

confidence: 69%

Prevalence of Peripheral Neuropathy in Type 2 Diabetic Patients Attending a Diabetes Center in Turkey

et al. 2004

View full text Add to dashboard Cite

Abstract. The aim of this study was to determine the prevalence and risk factors for neuropathy in type 2 diabetic patients attending a major Turkish diabetes center. Eight hundred and sixty-six consecutive type 2 diabetic patients were included in the study. A single observer performed biothesiometry studies on these patients. The presence of diabetic neuropathy was investigated using neurological symptom scale (NSS) and neurological disability score (NDS) performed. Neuropathy was determined with standardized neurological examinations and defined as the presence of abnormal NSS and NDS together with abnormal sensory or motor signs and symptoms as well as decreased great toe vibration perception. Overall, 60% (n = 520) of the patients were diagnosed as having neuropathy. The prevalence of neuropathy increased with age (p<0.001) and duration of diabetes (p<0.001). Multiple logistic regression analysis revealed the duration of diabetes (p<0.001) and HbA1c levels (p<0.001) as the risk factors for neuropathy. The overall prevalence of neuropathy in Turkish type 2 diabetic population was 60%. Age, duration of diabetes, and poor glycemic control were considered to be the risk factors for neuropathy.

show abstract

Section: Discussionsupporting

confidence: 69%

Prevalence of Peripheral Neuropathy in Type 2 Diabetic Patients Attending a Diabetes Center in Turkey

et al. 2004

View full text Add to dashboard Cite

show abstract

“…The findings were very similar to our study. Further, in the present study, the mean age and duration of diabetes was significantly higher in cases with neuropathy compared to cases without neuropathy which was statistically significant (p < 0.05), similar to a Spanish study, in which the prevalence of peripheral neuropathy increased from 14% at under five years duration to 44% at duration of more than 30 years 11 .…”

Section: Discussionsupporting

confidence: 90%

A Comparative Study of Various Bedside Methods in Detection of Diabetic Polyneuropathy in Type 2 Diabetes Patients

Mittal¹,

Khurana²,

Mahajan³

et al. 2013

jemds

View full text Add to dashboard Cite

Diabetes is a major public health problem. 285 million persons worldwide have diabetes, of these 51 million are in India. Diabetic peripheral neuropathy is a major microvascular complication of diabetes. Conventional methods used for the diagnosis of diabetic peripheral neuropathy in clinical practice have limited effectiveness. Since peripheral sensory neuropathy is a pivotal element in the causal pathway to both foot ulceration and amputation, screening and early identification of neuropathy offer a crucial opportunity for the patient with diabetes to actively modulate the course of suboptimal glycaemic control to currently recommended targets, and to implement improved foot care before the onset of significant morbidity. This study was carried out to evaluate the usefulness of simple bed side screening modalities for peripheral neuropathy like vibration perception threshold measurement with biothesiometer, 10g semmes-weinstein monofilament, diabetic neuropathy examination and symptom scores and ankle reflex testing in patients with diabetes mellitus and to seek an optimal screening method in diabetic clinic.

show abstract

“…21,30,31 It was to be found that the peripheral neuropathy was more common in females than males which was also observed by Alam 32 but contrast to other studies. 21,22,24,33 This study also revealed a significant association of peripheral neuropathy with non-urban(rural and semi urban) residence. The higher prevalence of DPN in non-urban participants may be due to referral bias, as this center was offering advance services for diabetic complications and commonly complicated than non-complicated diabetic patients from rural and suburban area came here.…”

Section: Hba 1c Categories (%)mentioning

confidence: 59%

“…The prevalence rate of DPN in Bangladeshis lower compared to European studies, [23][24][25] , which have reported an overall DPN prevalence of 32.1% (mean age: 63 years, mean duration of diabetes: six years); 23 35.4% (mean age: 61.3 years, mean duration of diabetes: 9.7 years) 24 and 60.0% (mean age: 57.2 ± 10.3, mean duration of diabetes: 8.52 ± 7.13 years) 25 among type 2 diabetic hospital outpatients. Studies from the UK showed a lower DPN prevalence among type 2 diabetic South-Asian patients compared with European patients living in the UK even after adjusting for age.…”

Section: Hba 1c Categories (%)mentioning

confidence: 77%

Evaluation of Different HbA1c Levels to Assess the Risk of Peripheral Neuropathy Among Type 2 Diabetic Patients Along With Other Conventional Risk Factors

Hoque¹,

Muttalib

Islam³

et al. 2017

Bangladesh Med Res Counc Bull

View full text Add to dashboard Cite

This cross sectional study was carried out in the outpatient department of Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, Bangladesh (BIRDEM) General Hospital, Dhaka, to explore the factors influencing or related to the development of the diabetic peripheral neuropathy (DPN) with specific concern to the HbA1c levels. A total of 400 patients with type 2 diabetic were selected to collect information on sociodemographic, blood pressure, anthropometry and lipid profile. Glycaemic status was assessed by HbA1c and plasma glucose levels. Prevalence of DPN was 16.8%, with male 10.8% and female 20.9%. Increased HbA1c categories above 7.0% were significantly associated with increased prevalence of DPN (9.2 Vs. 10.5 Vs 26.5%; χ 2 = 19.446, p = .000). Logistic regression models showed that the risk of DPN was strongly increased at the HbA1c categories ≥8% (OR = 3.57; 95% CI: 1.75-7.26). Advanced age (OR = 1.97; 95% CI: 1.12-3.47), longer duration of diabetes (OR = 1.81; 95% CI: 1.02-3.19), lacking of physical exercise (OR = 2.60; 95% CI: 1.47-4.58), female gender (OR = 2.17; 95% CI: 1.21-3.89), fasting blood glucose (OR = 1.153; 95% CI: 1.058-1.255) and blood glucose 2 hours after breakfast (OR = 1.096; 95% CI: 1.029-1.168) were significant risk factors of DPN. However, there is need of a large scale community based prospective study to validate the results.

show abstract

The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups

Cited by 171 publications

References 35 publications

Prevalence of Peripheral Neuropathy in Type 2 Diabetic Patients Attending a Diabetes Center in Turkey

Prevalence of Peripheral Neuropathy in Type 2 Diabetic Patients Attending a Diabetes Center in Turkey

A Comparative Study of Various Bedside Methods in Detection of Diabetic Polyneuropathy in Type 2 Diabetes Patients

Evaluation of Different HbA1c Levels to Assess the Risk of Peripheral Neuropathy Among Type 2 Diabetic Patients Along With Other Conventional Risk Factors

Contact Info

Product

Resources

About